NCT05675332 Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study
| NCT ID | NCT05675332 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Condition | Alcohol Drinking |
| Study Type | INTERVENTIONAL |
| Enrollment | 280 participants |
| Start Date | 2022-12-09 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 280 participants in total. It began in 2022-12-09 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the behavioral and neural correlates of stress exposure. Results from this study will enrich the understanding of how sociocultural, behavioral, and neural factors combine to influence alcohol use.
Eligibility Criteria
Inclusion Criteria: * Between 21 and 35 years of age (inclusive); * Fluent in English; * Right-handed Exclusion Criteria: * Younger than 21 years of age; * Left-handed
Contact & Investigator
Uraina Clark, PhD
PRINCIPAL INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Frequently Asked Questions
Who can join the NCT05675332 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 35 Years, studying Alcohol Drinking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05675332 currently recruiting?
Yes, NCT05675332 is actively recruiting participants. Contact the research team at shivani.doshi@mssm.edu for enrollment information.
Where is the NCT05675332 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05675332 clinical trial?
NCT05675332 is sponsored by Icahn School of Medicine at Mount Sinai. The principal investigator is Uraina Clark, PhD at Icahn School of Medicine at Mount Sinai. The trial plans to enroll 280 participants.